Participants with multiple sclerosis
are needed for a research study on:
Arbaclofen
(an extended release anti-spasticity investigational medication)
Purpose of the study –
Researchers from the University of Colorado Anschutz Medical Campus are conducting a clinical trial to compare the effectiveness and safety of arbaclofen extended release tablets to baclofen in MS patients with muscle spasticity.
You may be eligible to participate if you –
- Are between 18 and 65 years old
- Have clinically confirmed diagnosis of multiple sclerosis (MS)
- Are suffering from muscle spasticity for at least 6 months as a result of MS
Study participation involves –
- Approximately 10 visits over 5-6 months on the University of Colorado Anschutz Medical Campus
- Questionnaires, physical exams, and blood work
- Compensation for time and travel
If you are interested, please contact Bhavini Patel by calling 303-724-6351 or by email at bhavini.patel@ucdenver.edu to learn more about the study.
University of Colorado Denver-Principal Investigator: Augusto Miravalle, MD
Western Institutional Review Board (WIRB) approved Protocol # OS440-3002.
Version Date: 05/02/13